Mahaney Paige 4
4 · C4 Therapeutics, Inc. · Filed Oct 30, 2025
Insider Transaction Report
Form 4
Mahaney Paige
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2025-10-28$2.58/sh−5,644$14,562→ 99,356 total - Exercise/Conversion
Common Stock
2025-10-28+19,200→ 105,000 total
Footnotes (2)
- [F1]Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on October 28, 2024.
- [F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person.